CHARACTERIZATION AND DISTRIBUTION OF BINDING-SITES FOR A NEW NEUROTENSIN RECEPTOR ANTAGONIST LIGAND, [H-3] SR-48692, IN THE GUINEA-PIG BRAIN

被引:0
作者
BETANCUR, C
CANTON, M
GULLY, D
VELA, G
PELAPRAT, D
ROSTENE, W
机构
[1] HOP ST ANTOINE, INSERM, U339, F-75571 PARIS 12, FRANCE
[2] SANOFI RECH, F-31036 TOULOUSE, FRANCE
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
SR 48692, a selective nonpeptide antagonist of neurotensin (NT) receptors was developed recently. In the present work we studied the binding properties of the corresponding radioligand, [H-3]SR 48692, in the adult guinea pig brain. The characterization of [H-3]SR 48692 binding was carried out on brain membrane preparations and the distribution of [H-3]SR 48692 binding sites was determined by receptor au toradiography and compared to that of [I-125]NT binding sites. In brain homogenates, [3H]SR 48692 bound to a single population of sites with a K-d of 2.19 nM and a maximal binding capacity of 1.15 pmol/mg of protein. This maximal binding capacity value was 20 times higher than that observed for [I-125]NT. NT agonists were able to interact competitively with the entire population of binding sites labeled by [H-3]SR 48692, but their affinities were much lower than those observed for [I-125]NT. By contrast, NT antagonists exhibited similar abilities to inhibit the binding of both radioligands. The addition of unlabeled NT in saturation assays revealed a competitive inhibition of [H-3]SR 48692 binding, suggesting that agonist and antagonist ligand bind to overlapping domains of the NT receptor, The autoradiographic distribution of the low-affinity NT binding sites detected by [H-3]SR 48692 (96% of the receptors) was very similar to the distribution of high-affinity receptors labeled with [I-125]NT (4% of the receptors). In addition, the binding of [H-3]SR 48692 was insensitive to guanyl nucleotides. Taken together, these findings suggest that the binding sites detected by [H-3]SR 48692 in the guinea pig brain mainly represent the uncoupled form of the NT receptor.
引用
收藏
页码:1450 / 1458
页数:9
相关论文
共 47 条
[1]   STRUCTURE-ANTINOCICEPTIVE ACTIVITY OF NEUROTENSIN AND SOME NOVEL ANALOGS IN THE PERIAQUEDUCTAL GRAY REGION OF THE BRAIN-STEM [J].
ALRODHAN, NRF ;
RICHELSON, E ;
GILBERT, JA ;
MCCORMICK, DJ ;
KANBA, KS ;
PFENNING, MA ;
NELSON, A ;
LARSON, EW ;
YAKSH, TL .
BRAIN RESEARCH, 1991, 557 (1-2) :227-235
[2]   NEUROTENSIN RECEPTOR INTERACTION WITH DOPAMINERGIC SYSTEMS IN THE GUINEA-PIG BRAIN SHOWN BY NEUROTENSIN RECEPTOR ANTAGONISTS [J].
AZZI, M ;
GULLY, D ;
HEAULME, M ;
BEROD, A ;
PELAPRAT, D ;
KITABGI, P ;
BOIGEGRAIN, R ;
MAFFRAND, JP ;
LEFUR, G ;
ROSTENE, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 255 (1-3) :167-174
[3]   EFFECTS OF NEUROTENSIN ON DOPAMINE RELEASE AND METABOLISM IN THE RAT STRIATUM AND NUCLEUS-ACCUMBENS - CROSS-VALIDATION USING INVIVO VOLTAMMETRY AND MICRODIALYSIS [J].
BLAHA, CD ;
COURY, A ;
FIBIGER, HC ;
PHILLIPS, AG .
NEUROSCIENCE, 1990, 34 (03) :699-705
[4]  
BOIGEGRAIN R, 1992, Patent No. 477049
[5]   SR-48692 INHIBITS NEUROTENSIN-INDUCED [H-3] DOPAMINE RELEASE IN RAT STRIATAL SLICES AND MESENCEPHALIC CULTURES [J].
BROUARD, A ;
HEAULME, M ;
LEYRIS, R ;
PELAPRAT, D ;
GULLY, D ;
KITABGI, P ;
LEFUR, G ;
ROSTENE, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 253 (03) :289-291
[6]  
BROUARD A, 1992, J NEUROSCI, V12, P1409
[7]  
CARRAWAY R, 1973, J BIOL CHEM, V248, P6854
[8]  
CHANG RSL, 1986, MOL PHARMACOL, V30, P212
[9]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[10]   THE NONPEPTIDE NEUROTENSIN ANTAGONIST, SR-48692 USED AS A TOOL TO REVEAL PUTATIVE NEUROTENSIN RECEPTOR SUBTYPES [J].
DUBUC, I ;
COSTENTIN, J ;
TERRANOVA, JP ;
BARNOUIN, MC ;
SOUBRIE, P ;
LEFUR, G ;
ROSTENE, W ;
KITABGI, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (02) :352-354